أعرض في EDS

A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study

التفاصيل البيبلوغرافية
العنوان:	A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study
المؤلفون:	Manal F. Abdelmalek, Ayako Suzuki, Willian Sanchez, Eric Lawitz, Claudia Filozof, Hyungjin Cho, Eunhye Baek, JaeDuk Choi, Seungjae Baek
المصدر:	Contemporary Clinical Trials. 130:107176
بيانات النشر:	Elsevier BV, 2023.
سنة النشر:	2023
مصطلحات موضوعية:	Pharmacology (medical), General Medicine
تدمد:	1551-7144
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=doi_________::b0297e468f57531a570dd8b6d57efe7dTest https://doi.org/10.1016/j.cct.2023.107176Test
حقوق:	CLOSED
رقم الانضمام:	edsair.doi...........b0297e468f57531a570dd8b6d57efe7d
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	15517144